Stock Earnings Ovid Therapeutics Inc (OVID) gets rating Downgrade from Oppenheimer Ovid Therapeutics Inc’s filing revealed that its President and COO ALEXANDER MARGARET A. unloaded Company’s shares for reported $2956.0 on
News 4 Trending Companies to Trade Today Most of the major indices posted gains yesterday, with the S&P 500 and DJIA advancing more than 10%. The NASDAQ